Limits...
Results of renal re-transplant in Spain (1990-2002).

Guirado L, Ruiz JC, Andrés A, Rengel M, Escuin F, Ortega F, Romero R, Díaz JM, Beneyto I, Morales JM - NDT Plus (2010)

Bottom Line: The actuarial patient survival was 85% at 10 years and 80% at 15 years.During the period of follow-up, 28.6% of the grafts were lost.The actuarial graft survival was 75% at 10 years and 58% at 15 years.

View Article: PubMed Central - PubMed

ABSTRACT
Background. Renal re-transplants are increasing in number, due to many first renal transplant patients coming back to dialysis treatment. There are controversial opinions about the evolution of these re-transplanted patients. The aim of our study is to analyse the prognosis of patients and grafts under a renal re-transplant.Methods. This was a retrospective study of 579 renal re-transplants realized in 15 Spanish different centres in the years 1990, 1994, 1998 and 2002 including all renal re-transplants realized in the above-mentioned centres during the same periods.Results. During the follow-up period, 8.81% of patients died. The actuarial patient survival was 85% at 10 years and 80% at 15 years. Principal reasons of death were the same as normal for the renal transplanted patient: cardiovascular (30.77%), infectious (13.46%) and neoplastic (13.46%). During the period of follow-up, 28.6% of the grafts were lost. The actuarial graft survival was 75% at 10 years and 58% at 15 years. Causes of graft loss are very similar to those described in literature.Conclusion. Renal re-transplant is a kind of substitute renal treatment with excellent clinical results that allow to take it as a first-order modality of treatment when the first renal transplant has failed.

No MeSH data available.


Related in: MedlinePlus

Evolution of plasmatic creatinine in renal re-transplanted patients.
© Copyright Policy - creative-commons
Related In: Results  -  Collection

License
getmorefigures.php?uid=PMC2875046&req=5

fig1: Evolution of plasmatic creatinine in renal re-transplanted patients.

Mentions: Renal function and proteinuria. Patients were kept stable along the follow-up as shown in Figure 1. One year after transplant, 30.4% of patients had a plasmatic creatinine between 0.5 and 1.2 mg/dL, 50% between 1.3 and 2 mg/dL, 14.4% between 2.1 and 3 mg/dL and 5.1% >3 mg/dL.


Results of renal re-transplant in Spain (1990-2002).

Guirado L, Ruiz JC, Andrés A, Rengel M, Escuin F, Ortega F, Romero R, Díaz JM, Beneyto I, Morales JM - NDT Plus (2010)

Evolution of plasmatic creatinine in renal re-transplanted patients.
© Copyright Policy - creative-commons
Related In: Results  -  Collection

License
Show All Figures
getmorefigures.php?uid=PMC2875046&req=5

fig1: Evolution of plasmatic creatinine in renal re-transplanted patients.
Mentions: Renal function and proteinuria. Patients were kept stable along the follow-up as shown in Figure 1. One year after transplant, 30.4% of patients had a plasmatic creatinine between 0.5 and 1.2 mg/dL, 50% between 1.3 and 2 mg/dL, 14.4% between 2.1 and 3 mg/dL and 5.1% >3 mg/dL.

Bottom Line: The actuarial patient survival was 85% at 10 years and 80% at 15 years.During the period of follow-up, 28.6% of the grafts were lost.The actuarial graft survival was 75% at 10 years and 58% at 15 years.

View Article: PubMed Central - PubMed

ABSTRACT
Background. Renal re-transplants are increasing in number, due to many first renal transplant patients coming back to dialysis treatment. There are controversial opinions about the evolution of these re-transplanted patients. The aim of our study is to analyse the prognosis of patients and grafts under a renal re-transplant.Methods. This was a retrospective study of 579 renal re-transplants realized in 15 Spanish different centres in the years 1990, 1994, 1998 and 2002 including all renal re-transplants realized in the above-mentioned centres during the same periods.Results. During the follow-up period, 8.81% of patients died. The actuarial patient survival was 85% at 10 years and 80% at 15 years. Principal reasons of death were the same as normal for the renal transplanted patient: cardiovascular (30.77%), infectious (13.46%) and neoplastic (13.46%). During the period of follow-up, 28.6% of the grafts were lost. The actuarial graft survival was 75% at 10 years and 58% at 15 years. Causes of graft loss are very similar to those described in literature.Conclusion. Renal re-transplant is a kind of substitute renal treatment with excellent clinical results that allow to take it as a first-order modality of treatment when the first renal transplant has failed.

No MeSH data available.


Related in: MedlinePlus